Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000899923-26-000057
Filing Date
2026-06-04
Accepted
2026-06-04 16:05:37
Documents
18
Effectiveness Date
2026-06-04

Document Format Files

Seq Description Document Type Size
1 S-8 myriad-formsx82026planjune.htm S-8 92180
2 EX 107 FILING FEE TABLE exfilingfees.htm   iXBRL EX-FILING FEES 16484
3 EX-5.1 ex-512026planmintzopinion.htm EX-5.1 13248
4 EX-23.1 ex-231consent_2026xplan.htm EX-23.1 2133
5 EX-99.1 ex991myriad-2026employeedi.htm EX-99.1 151629
6 EX-99.2 ex992rsuagreement2026pland.htm EX-99.2 40631
7 EX-99.3 ex993rsuagreement2026plane.htm EX-99.3 46064
8 GRAPHIC image_1.jpg GRAPHIC 5350
9 GRAHIC image_2.jpg GRAPHIC 11510
  Complete submission text file 0000899923-26-000057.txt   506387

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 5198
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296486 | Film No.: 261064911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)